Max Robotics — Global Service Robot Directory + US Certification

About

Carlo Schippers is a leading surgical oncologist whose research has transformed the treatment of esophageal cancer through the advancement of robot-assisted minimally invasive thoracolaparoscopic esophagectomy (RAMIE). His landmark randomized controlled trial, the ROBOT trial, demonstrated that RAMIE significantly reduces perioperative complications compared to open transthoracic esophagectomy, establishing a new standard of care for resectable esophageal cancer. With over 640 citations, his 2018 study on RAMIE versus open surgery is a cornerstone in the field, showing that robotic techniques can achieve superior outcomes without compromising oncologic efficacy. Schippers has also pioneered enhanced recovery after surgery (ERAS) protocols for esophagectomy, optimizing postoperative care in high-volume centers. His work has been instrumental in shifting surgical practice toward minimally invasive approaches, improving recovery times and quality of life for patients worldwide. As a high-impact researcher, Schippers continues to shape the future of esophageal cancer surgery, bridging the gap between technological innovation and patient-centered care.